Home » Topics » BioWorld

BioWorld
RSS

ONCORAD TRIALS FOR PROSTATE CANCER

Aug. 21, 1992

DIETARY SUPPLEMENT FOR PARKINSON'S

Aug. 21, 1992

BRAIN DAMAGE DRUG ENTERS CLINICALS

Aug. 21, 1992

ASSAY REPORTEDLY IDS ALZHEIMER'S PATIENTS

Aug. 21, 1992

LEECO TO RESTRUCTURE

Aug. 20, 1992

RAPID GROWTH OF AG BIOTECH SEEN

Aug. 20, 1992

NEOGEN TO DEVELOP TESTS FOR PFIZER

Aug. 20, 1992

NAVY CONTRACT FOR NORTH AMERICAN BIOLOGICALS

Aug. 20, 1992

TRANSGENIC FIRM AWAITS IPO

Aug. 20, 1992

ARGUS PATENT ALLOWED FOR ANTI-FUNGAL

Aug. 20, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...